Moneycontrol

You are Here : 'Doubt Ranbaxy claim that Mohali product filings not hit'

Monday, 11:16

The question that needs to be resolved is what exactly is happening in terms of product filing and why is Ranbaxy saying that the product filings have not been impacted, says Vikas Dandekar, India Bureau Chief, PharmAsiaNews.Com.
JUN 28, 2017
04:02 AM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On